NCT02054351 Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR) Status COMPLETED Phase PHASE1
NCT02043158 Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02042885 A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT02039388 Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma Status COMPLETED Phase NA
NCT02033551 A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT02019524 Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients Status COMPLETED Phase PHASE1
NCT02017678 Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin Status WITHDRAWN Phase PHASE2
NCT02015416 A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT02009631 A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT02009449 A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02004093 A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer Status COMPLETED Phase PHASE2
NCT02001272 EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01997190 Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion Status COMPLETED Phase PHASE1
NCT01991210 A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC) Status TERMINATED Phase PHASE2
NCT01982500 Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer Status COMPLETED Phase N/A
NCT01977274 Predictive Clinical and Biological Parameters in Gynecological Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT01975831 A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab Status COMPLETED Phase PHASE1